Almond protects the liver in coronary artery disease – a randomized controlled clinical trial

Objective: To compare the effect of Pakistani and American almonds on serum concentration of liver enzymes in coronary artery disease patients. Methods: The randomised controlled trial was conducted at the Cardiology Clinics of Aga Khan University Hospital, Karachi, from February to July, 2012, a...

Full description

Bibliographic Details
Main Authors: Humaira Jamshed, Jamshed Arslan, Fatehali Tipoo Sultan, Hasan Salman Siddiqi, Muhammad Qasim, Anwar-ul-Hassan Gilani, Admin
Format: Article
Language:English
Published: Pakistan Medical Association 2020-11-01
Series:Journal of the Pakistan Medical Association
Online Access:https://www.ojs.jpma.org.pk/index.php/public_html/article/view/613
_version_ 1797820686575599616
author Humaira Jamshed
Jamshed Arslan
Fatehali Tipoo Sultan
Hasan Salman Siddiqi
Muhammad Qasim
Anwar-ul-Hassan Gilani
Admin
author_facet Humaira Jamshed
Jamshed Arslan
Fatehali Tipoo Sultan
Hasan Salman Siddiqi
Muhammad Qasim
Anwar-ul-Hassan Gilani
Admin
author_sort Humaira Jamshed
collection DOAJ
description Objective: To compare the effect of Pakistani and American almonds on serum concentration of liver enzymes in coronary artery disease patients. Methods: The randomised controlled trial was conducted at the Cardiology Clinics of Aga Khan University Hospital, Karachi, from February to July, 2012, and comprised patients who were randomised into intervention PA and AA groups and the control NI groups. Subjects in the intervention groups were provided Pakistani and American varieties of almonds 10g/day respectively with instructions to soak them overnight, remove the skin and eat them before breakfast for 12 weeks. The control group underwent no intervention. Serum concentrations of aspartate transaminase, Alanine transaminase and gamma-glutamyl transferase were analysed and compared. Results: Of the 150 subjects, 110(73.3%) completed the study. Of them, there were 38(34.5%) in PA group, 41(37.3%) in AA, and 31(28.2%) in the NI group. Dietary almonds significantly reduced serum concentrations of aspartate transaminase, alanine transaminase and gamma-glutamyl transferase in the two intervention groups compared to the controls group (p<0.05) at 12-week follow-up. Conclusion: A low dose of almonds was found to be an effective strategy to protect the liver. Key Words: Low dose, Soaked almonds, Transaminases, Transpeptidase, SGOT/SGPT. Continuous...
first_indexed 2024-03-13T09:41:55Z
format Article
id doaj.art-da48ed04578a4e80b62cd42cc6235d39
institution Directory Open Access Journal
issn 0030-9982
language English
last_indexed 2024-03-13T09:41:55Z
publishDate 2020-11-01
publisher Pakistan Medical Association
record_format Article
series Journal of the Pakistan Medical Association
spelling doaj.art-da48ed04578a4e80b62cd42cc6235d392023-05-25T04:24:49ZengPakistan Medical AssociationJournal of the Pakistan Medical Association0030-99822020-11-0171310.47391/JPMA.198Almond protects the liver in coronary artery disease – a randomized controlled clinical trialHumaira Jamshed0Jamshed Arslan1Fatehali Tipoo Sultan2Hasan Salman Siddiqi3Muhammad Qasim4Anwar-ul-Hassan Gilani 5AdminUniversity of Albama, Birmingham, AlbamaUniversity of Albama, Birmingham, AlbamaAga Khan University, Karachi, Pakistan.Aga Khan University, Karachi, Pakistan.Aga Khan University, Karachi, Pakistan.Aga Khan University, Karachi, Pakistan. Objective: To compare the effect of Pakistani and American almonds on serum concentration of liver enzymes in coronary artery disease patients. Methods: The randomised controlled trial was conducted at the Cardiology Clinics of Aga Khan University Hospital, Karachi, from February to July, 2012, and comprised patients who were randomised into intervention PA and AA groups and the control NI groups. Subjects in the intervention groups were provided Pakistani and American varieties of almonds 10g/day respectively with instructions to soak them overnight, remove the skin and eat them before breakfast for 12 weeks. The control group underwent no intervention. Serum concentrations of aspartate transaminase, Alanine transaminase and gamma-glutamyl transferase were analysed and compared. Results: Of the 150 subjects, 110(73.3%) completed the study. Of them, there were 38(34.5%) in PA group, 41(37.3%) in AA, and 31(28.2%) in the NI group. Dietary almonds significantly reduced serum concentrations of aspartate transaminase, alanine transaminase and gamma-glutamyl transferase in the two intervention groups compared to the controls group (p<0.05) at 12-week follow-up. Conclusion: A low dose of almonds was found to be an effective strategy to protect the liver. Key Words: Low dose, Soaked almonds, Transaminases, Transpeptidase, SGOT/SGPT. Continuous... https://www.ojs.jpma.org.pk/index.php/public_html/article/view/613
spellingShingle Humaira Jamshed
Jamshed Arslan
Fatehali Tipoo Sultan
Hasan Salman Siddiqi
Muhammad Qasim
Anwar-ul-Hassan Gilani
Admin
Almond protects the liver in coronary artery disease – a randomized controlled clinical trial
Journal of the Pakistan Medical Association
title Almond protects the liver in coronary artery disease – a randomized controlled clinical trial
title_full Almond protects the liver in coronary artery disease – a randomized controlled clinical trial
title_fullStr Almond protects the liver in coronary artery disease – a randomized controlled clinical trial
title_full_unstemmed Almond protects the liver in coronary artery disease – a randomized controlled clinical trial
title_short Almond protects the liver in coronary artery disease – a randomized controlled clinical trial
title_sort almond protects the liver in coronary artery disease a randomized controlled clinical trial
url https://www.ojs.jpma.org.pk/index.php/public_html/article/view/613
work_keys_str_mv AT humairajamshed almondprotectstheliverincoronaryarterydiseasearandomizedcontrolledclinicaltrial
AT jamshedarslan almondprotectstheliverincoronaryarterydiseasearandomizedcontrolledclinicaltrial
AT fatehalitipoosultan almondprotectstheliverincoronaryarterydiseasearandomizedcontrolledclinicaltrial
AT hasansalmansiddiqi almondprotectstheliverincoronaryarterydiseasearandomizedcontrolledclinicaltrial
AT muhammadqasim almondprotectstheliverincoronaryarterydiseasearandomizedcontrolledclinicaltrial
AT anwarulhassangilani almondprotectstheliverincoronaryarterydiseasearandomizedcontrolledclinicaltrial
AT admin almondprotectstheliverincoronaryarterydiseasearandomizedcontrolledclinicaltrial